Gong Christine, Bertagnolli Lynn N, Boulton David W, Coppola Paola
University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania, USA.
Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca LP, Gaithersburg, Maryland, USA.
CPT Pharmacometrics Syst Pharmacol. 2024 Nov;13(11):1870-1880. doi: 10.1002/psp4.13195. Epub 2024 Jul 7.
Despite the benefits of breastfeeding, lactating mothers who take prescribed medications may discontinue breastfeeding due to concerns associated with infant drug exposure in breastmilk. Consolidating the current knowledge of drug transport to breastmilk may inform understanding of the safety of medication use during lactation. This literature review summarizes the mechanisms of drug transport to breastmilk, details the physicochemical drug properties that may alter the extent of passive transport, and describes the expressional changes in mammary drug transporters that may affect active transport. During the period of 20 July 2023 to 11 August 2023, PubMed® was searched to identify journal articles pertinent to the mechanisms of drug transport from maternal plasma to breastmilk and the expression of mammary drug transporters during lactation. From the 28 studies included in this review, four mechanisms were identified for transporting drugs from maternal plasma to breastmilk: passive transport, active transport, lipid co-transport, and transcytosis. The lactational expression of 20 drug transporters was further summarized, with 9 transporters demonstrating downregulated expression during lactation and 11 transporters demonstrating upregulated expression during lactation. Understanding the mechanisms of drug transport to breastmilk may aid in estimating infant drug exposure, developing physiologically based pharmacokinetic (PBPK) models that describe drug transfer, and initiating clinical drug development programs in the lactating population.
尽管母乳喂养有诸多益处,但服用处方药的哺乳期母亲可能会因担心母乳中的药物暴露对婴儿产生影响而停止母乳喂养。整合目前关于药物转运至母乳的知识,有助于理解哺乳期用药的安全性。这篇文献综述总结了药物转运至母乳的机制,详述了可能改变被动转运程度的药物理化性质,并描述了可能影响主动转运的乳腺药物转运体的表达变化。在2023年7月20日至2023年8月11日期间,检索了PubMed®,以确定与药物从母体血浆转运至母乳的机制以及哺乳期乳腺药物转运体表达相关的期刊文章。从本综述纳入的28项研究中,确定了四种将药物从母体血浆转运至母乳的机制:被动转运、主动转运、脂质共转运和转胞吞作用。进一步总结了20种药物转运体在哺乳期的表达情况,其中9种转运体在哺乳期表达下调,11种转运体在哺乳期表达上调。了解药物转运至母乳的机制可能有助于评估婴儿的药物暴露情况,建立描述药物转运的生理药代动力学(PBPK)模型,并启动哺乳期人群的临床药物研发项目。